Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer’s Disease and Type 2 Diabetes
出版年份 2017 全文链接
标题
Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer’s Disease and Type 2 Diabetes
作者
关键词
Alzheimer’s disease, Type 2 diabetes, Polypill, Amyloid-beta, Tau, Hemorrhage, Inflammation
出版物
MOLECULAR NEUROBIOLOGY
Volume 55, Issue 7, Pages 6130-6144
出版商
Springer Nature
发表日期
2017-12-09
DOI
10.1007/s12035-017-0825-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
- (2018) Tze Pin Ng et al. JOURNAL OF ALZHEIMERS DISEASE
- Simvastatin ameliorates memory impairment and neurotoxicity in streptozotocin-induced diabetic mice
- (2017) Shun-Chang Fang et al. NEUROSCIENCE
- Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players
- (2016) Nicoleta Alexandru et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Angiotensin converting enzyme serum activities: Relationship with Alzheimer’s disease
- (2016) Shan Zhuang et al. BRAIN RESEARCH
- Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice
- (2016) Wilma Helena Oliveira et al. BRAIN RESEARCH
- Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension
- (2016) Yi-Chun Kuan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation
- (2016) Sung Min Son et al. JOURNAL OF ALZHEIMERS DISEASE
- Angiotensin Converting Enzyme Inhibitors Ameliorate Brain Inflammation Associated with Microglial Activation: Possible Implications for Alzheimer’s Disease
- (2016) Nofar Torika et al. Journal of Neuroimmune Pharmacology
- Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
- (2016) Erica Barini et al. Molecular Neurodegeneration
- Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer’s disease and type 2 diabetes
- (2016) Carmen Infante-Garcia et al. PSYCHONEUROENDOCRINOLOGY
- Quantification of simvastatin in mice plasma by near-infrared and chemometric analysis of spectral data
- (2016) Usama Fahmy Drug Design Development and Therapy
- Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect
- (2015) Pasquale Picone et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Increased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus
- (2015) Juan José Ramos-Rodriguez et al. MOLECULAR NEUROBIOLOGY
- Hypertension exacerbates predisposition to neurodegeneration and memory impairment in the presence of a neuroinflammatory stimulus: Protection by angiotensin converting enzyme inhibition
- (2015) Ruby Goel et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease
- (2015) Juan Jose Ramos-Rodriguez et al. PSYCHONEUROENDOCRINOLOGY
- Central Proliferation and Neurogenesis Is Impaired in Type 2 Diabetes and Prediabetes Animal Models
- (2014) Juan Jose Ramos-Rodriguez et al. PLoS One
- Effects of Statins on Incident Dementia in Patients with Type 2 DM: A Population-Based Retrospective Cohort Study in Taiwan
- (2014) Jui-Ming Chen et al. PLoS One
- The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex
- (2014) Moritz M. Hettich et al. PLoS One
- The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
- (2013) Patrick L. McGeer et al. ACTA NEUROPATHOLOGICA
- Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
- (2013) E. M. Moore et al. DIABETES CARE
- Rapid β-Amyloid Deposition and Cognitive Impairment After Cholinergic Denervation in APP/PS1 Mice
- (2013) Juan Jose Ramos-Rodriguez et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice
- (2013) Panayiota Papadopoulos et al. NEUROBIOLOGY OF AGING
- Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice
- (2013) Juan Jose Ramos-Rodriguez et al. PSYCHONEUROENDOCRINOLOGY
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Deregulation of Protein Phosphatase 2A and Hyperphosphorylation of Protein Following Onset of Diabetes in NOD Mice
- (2012) M.-A. Papon et al. DIABETES
- Effects of statins and cholesterol on memory functions in mice
- (2012) Ravindra M. Ghodke et al. METABOLIC BRAIN DISEASE
- Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice
- (2012) Jiejie Li et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?
- (2011) Sónia C. Correia et al. AGEING RESEARCH REVIEWS
- Cerebrovascular lesions induce transient -amyloid deposition
- (2011) M. Garcia-Alloza et al. BRAIN
- Metformin restores endothelial function in aorta of diabetic rats
- (2011) Cristina M Sena et al. BRITISH JOURNAL OF PHARMACOLOGY
- Low Dose Aspirin Therapy Decreases Blood Glucose Levels but Does not Prevent Type I Diabetes-induced Bone Loss
- (2011) Lindsay M. Coe et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease
- (2011) Yi-Fei Dong et al. FASEB JOURNAL
- Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance
- (2010) Mitsuru Shinohara et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study
- (2010) E. M. C. Schrijvers et al. NEUROLOGY
- Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
- (2010) E. Kickstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A deposition in an Alzheimer mouse model with diabetes
- (2010) S. Takeda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- White Matter Damage and the Effect of Matrix Metalloproteinases in Type 2 Diabetic Mice After Stroke
- (2010) Jieli Chen et al. STROKE
- The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia
- (2009) Suzanne Craft ARCHIVES OF NEUROLOGY
- Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging
- (2009) Wolfgang Lieb JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Statins Reduce the Neurofibrillary Tangle Burden in a Mouse Model of Tauopathy
- (2009) Moran Boimel et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and Diabetes Mellitus type-2
- (2009) Massimiliano Plastino et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice
- (2008) Randy Strong et al. AGING CELL
- An aspirin a day for Alzheimer's disease?
- (2008) Paul S Aisen LANCET NEUROLOGY
- Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
- (2008) Raj N Kalaria et al. LANCET NEUROLOGY
- Amyloid beta oligomers induce impairment of neuronal insulin receptors
- (2007) Wei-Qin Zhao et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More